- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Meningococcal disease
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Multicomponent Meningococcal group B vaccine – November 2019
Multicomponent Meningococcal group B vaccine: Injection 0.5 mL; Bexsero®
Last updated
9 July 2025